Results 61 to 70 of about 9,904 (185)

Распадаемость агломератов в процессе высвобождения из ингалятора [PDF]

open access: yes, 2018
Представлены результаты экспериментальных исследований фракционного состава микронизированной активной фармацевтической субстанции Сальметерола ксинафоат при выходе из однодозового порошкового ингалятора.
Иванов, Н. А.   +2 more
core   +2 more sources

Asthma Control: The Right Inhaler for the Right Patient. [PDF]

open access: yes, 2015
Inhaled therapy is the cornerstone of asthma management in that it optimizes the delivery of the medication to the site of action. The effectiveness of inhaled therapy is affected by the correct choice of the device and proper inhalation technique.
SCICHILONE, Nicola Alessandro
core   +2 more sources

Excipient-API interactions in dry powder inhalers

open access: yesJournal of Excipients and Food Chemicals, 2016
There remains a paucity of predictive models to evaluate the suitability of excipients or excipient mixtures for dry powder inhalers because a large number of interdependent variables affect both formulation and inhaler performance.
Shireesh Apte
doaj  

Impact of selected construction elements of capsule-based dry powder inhalers on the manner of drug delivery to the lungs

open access: yesPediatria i Medycyna Rodzinna, 2016
The article discusses selected issues related to construction and performance of dry powder inhalers with the spinning capsule: Aerolizer® and cyclohaler.
Marcin Odziomek, Tomasz R. Sosnowski
doaj   +1 more source

Salbutamol powder inhaled from the Diskhaler compared to salbutamol as nebulizer solution in severe chronic airways obstruction [PDF]

open access: yes, 1995
The bronchodilatory effect of four doses of salbutamol powder (1·6 mg) from a multi-dose dry powder inhaler, the Diskhaler, was compared to the effect of 2·5 ml salbutamol nebulizer solution (1 mg ml−1) from a jet nebulizer, Pari Inhalierboy, in a ...
Buijs, Pascal   +5 more
core   +7 more sources

Excipient-API interactions in dry powder inhalers [PDF]

open access: yesJournal of Excipients and Food Chemicals
There remains a paucity of predictive models to evaluate the suitability of excipients or excipient mixtures for dry powder inhalers because a large number of interdependent variables affect both formulation and inhaler performance.
Shireesh Apte
doaj  

The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study [PDF]

open access: yes, 2017
Rupert Jones,1 Jessica Martin,2 Vicky Thomas,3 Derek Skinner,4 Jonathan Marshall,5 Martina Stagno d’Alcontres,2 David Price2,6 1Clinical Trials and Health Research, Institute of Translational and Stratified Medicine, Plymouth University Peninsula ...
Jones, R   +6 more
core   +2 more sources

Effect of novel inhaler technique reminder labels on the retention of inhaler technique skills in asthma: a single-blind randomized controlled trial

open access: yesnpj Primary Care Respiratory Medicine, 2017
Asthma: Reminder labels improve inhaler technique Personalized labels on asthma inhalers remind patients of correct technique and help improve symptoms over time. Iman Basheti at the Applied Science Private University in Jordan and co-workers trialed the
Iman A. Basheti   +2 more
doaj   +1 more source

Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control [PDF]

open access: yes, 2009
Background As more inhaled corticosteroid (ICS) devices become available, there may be pressure for health-care providers to switch patients with asthma to cheaper inhaler devices. Our objective was to evaluate impact on asthma control of inhaler device
Mike Thomas   +27 more
core   +1 more source

Regular treatment with formoterol for chronic asthma: serious adverse events [PDF]

open access: yes, 2012
Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are safe ...
Altman   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy